The reported statements, read against the company's own industry.
Financials view
Market Capitalization
57.22BUSD
vs all stocks (USD)
Updated Oct 27, 2026
Trailing P/E
42.59x
vs Scientific & Technical Instruments peers
Updated Oct 27, 2026
Revenue (TTM)
6.58BUSD
vs all stocks (USD)
Updated Oct 27, 2026
Profit Margin
19.14%
vs Scientific & Technical Instruments peers
Updated Oct 27, 2026
Beta
1.18x
vs all stocks
Updated Oct 27, 2026
52-Week Change
97.66%
vs all stocks
Updated Oct 27, 2026
Forward Annual Dividend Yield
0.00%
vs all stocks
Updated Oct 27, 2026
Market Capitalization
57.22BUSD
vs all stocks (USD)
Updated Oct 27, 2026
Enterprise Value
53.75BUSD
vs all stocks (USD)
Updated Oct 27, 2026
Trailing P/E
42.59x
vs Scientific & Technical Instruments peers
Updated Oct 27, 2026
Forward P/E
22.59x
vs Scientific & Technical Instruments peers
Updated Oct 27, 2026
PEG Ratio
0.3875x
vs Scientific & Technical Instruments peers
Updated Oct 27, 2026
Price to Sales (TTM)
8.14x
vs Scientific & Technical Instruments peers
Provider-reported. Market Capitalization ÷ Revenue (TTM) on this page gives 8.69×.Updated Oct 27, 2026
Price to Book (MRQ)
8.16x
vs Scientific & Technical Instruments peers
Updated Oct 27, 2026
Enterprise to Revenue
8.17x
vs Scientific & Technical Instruments peers
Updated Oct 27, 2026
Enterprise to EBITDA
31.65x
vs Scientific & Technical Instruments peers
Provider-reported. Enterprise Value ÷ EBITDA (TTM) on this page gives 28.05×.Updated Oct 27, 2026
Gross Margin
65.87%
vs Scientific & Technical Instruments peers
Provider-reported. Gross Profit (TTM) ÷ Revenue (TTM) on this page gives 63.28%.Updated Oct 27, 2026
Profit Margin
19.14%
vs Scientific & Technical Instruments peers
Updated Oct 27, 2026
Operating Margin
25.68%
vs Scientific & Technical Instruments peers
Updated Oct 27, 2026
Return on Assets (TTM)
7.23%
vs Scientific & Technical Instruments peers
Updated Oct 27, 2026
Return on Equity (TTM)
20.90%
vs Scientific & Technical Instruments peers
Updated Oct 27, 2026
Revenue (TTM)
6.58BUSD
vs all stocks (USD)
Updated Oct 27, 2026
Revenue per Share (TTM)
38.44USDUpdated Oct 27, 2026
Quarterly Revenue Growth
36.50%
vs Scientific & Technical Instruments peers
Updated Oct 27, 2026
Gross Profit (TTM)
4.16BUSD
vs all stocks (USD)
Updated Oct 27, 2026
EBITDA (TTM)
1.92BUSD
vs all stocks (USD)
Updated Oct 27, 2026
Net Income (TTM)
1.28BUSD
vs all stocks (USD)
Updated Oct 27, 2026
Quarterly Earnings Growth (YoY)
107.90%
vs Scientific & Technical Instruments peers
Updated Oct 27, 2026
Operating Cash Flow (TTM)
1.60BUSD
vs all stocks (USD)
Updated Oct 27, 2026
Levered Free Cash Flow (TTM)
1.87BUSD
vs all stocks (USD)
Updated Oct 27, 2026
Forward Annual Dividend Yield
0.00%
vs all stocks
Updated Oct 27, 2026
Trailing Annual Dividend Rate
0.00USDUpdated Oct 27, 2026
Trailing Annual Dividend Yield
0.00%
vs all stocks
Updated Oct 27, 2026
Payout Ratio
0.00%
vs Scientific & Technical Instruments peers
Updated Oct 27, 2026
Minority Interest (Equity)
0.00USDFY2025 · Oct 31, 2025
Revenue
5.38BUSDFY2025 · Oct 31, 2025
Cost of Goods Sold
2.04BUSDFY2025 · Oct 31, 2025
Gross Profit
3.34BUSDFY2025 · Oct 31, 2025
Operating Income
876.00MUSD
vs all stocks (USD)
FY2025 · Oct 31, 2025
Pre-tax Income
1.08BUSDFY2025 · Oct 31, 2025
Income Tax Expense
213.00MUSDFY2025 · Oct 31, 2025
Net Income
850.00MUSDFY2025 · Oct 31, 2025
EBIT
1.18BUSDFY2025 · Oct 31, 2025
EBITDA (Income Statement)
1.45BUSDFY2025 · Oct 31, 2025
Research & Development
1.01BUSDFY2025 · Oct 31, 2025
Selling, General & Administrative
1.47BUSDFY2025 · Oct 31, 2025
Other Operating Expenses
-20.00MUSDFY2025 · Oct 31, 2025
Non-operating Interest Income
102.00MUSDFY2025 · Oct 31, 2025
Non-operating Interest Expense
96.00MUSDFY2025 · Oct 31, 2025
EPS (Basic)
4.91USDFY2025 · Oct 31, 2025
EPS (Diluted)
4.89USDFY2025 · Oct 31, 2025
Basic Shares Outstanding
172.00MSharesFY2025 · Oct 31, 2025
Diluted Shares Outstanding
172.00MSharesFY2025 · Oct 31, 2025
Net Income from Continuing Operations
850.00MUSDFY2025 · Oct 31, 2025
Operating Cash Flow
1.42BUSDFY2025 · Oct 31, 2025
Free Cash Flow
1.29BUSDFY2025 · Oct 31, 2025
Cash & Cash Equivalents (End of Period)
1.89BUSDFY2025 · Oct 31, 2025
Income Tax Paid
120.00MUSDFY2025 · Oct 31, 2025
Interest Paid
77.00MUSDFY2025 · Oct 31, 2025
Starting Profit (CF Statement)
850.00MUSDFY2025 · Oct 31, 2025
Depreciation & Amortization
276.00MUSDFY2025 · Oct 31, 2025
Deferred Taxes (CF)
-116.00MUSDFY2025 · Oct 31, 2025
Stock-based Compensation
162.00MUSDFY2025 · Oct 31, 2025
Other Non-cash Items
49.00MUSDFY2025 · Oct 31, 2025
Change in Accounts Receivable (CF)
128.00MUSDFY2025 · Oct 31, 2025
Change in Accounts Payable (CF)
26.00MUSDFY2025 · Oct 31, 2025
Change in Other Assets/Liabilities
43.00MUSDFY2025 · Oct 31, 2025
Capital Expenditures
-128.00MUSDFY2025 · Oct 31, 2025
Net Acquisitions
-1.62BUSDFY2025 · Oct 31, 2025
Sale of Investments
30.00MUSDFY2025 · Oct 31, 2025
Other Investing Activity
-6.00MUSDFY2025 · Oct 31, 2025
Net Investing Cash Flow
-1.73BUSDFY2025 · Oct 31, 2025
Long-term Debt Issuance
748.00MUSDFY2025 · Oct 31, 2025
Long-term Debt Payments
0.00USDFY2025 · Oct 31, 2025
Common Stock Repurchase
-377.00MUSDFY2025 · Oct 31, 2025
Other Financing Charges
-49.00MUSDFY2025 · Oct 31, 2025
Net Financing Cash Flow
322.00MUSDFY2025 · Oct 31, 2025
Shares Outstanding
170.30MSharesUpdated Oct 27, 2026
Float Shares
169.11MSharesUpdated Oct 27, 2026
Shares Short
2.44MSharesUpdated Oct 27, 2026
Short Ratio
2.40days
vs all stocks
Updated Oct 27, 2026
Short % of Shares Outstanding
1.64%
vs all stocks
Updated Oct 27, 2026
% Held by Insiders
0.58%
vs all stocks
Updated Oct 27, 2026
% Held by Institutions
93.33%
vs all stocks
Updated Oct 27, 2026
Total Cash (MRQ)
2.60BUSD
vs all stocks (USD)
Updated Oct 27, 2026
Total Cash per Share (MRQ)
15.30USDUpdated Oct 27, 2026
Total Debt (MRQ)
2.77BUSD
vs all stocks (USD)
Updated Oct 27, 2026
Total Debt to Equity (MRQ)
0.4209x
vs Scientific & Technical Instruments peers
Updated Oct 27, 2026
Current Ratio (MRQ)
2.02x
vs Scientific & Technical Instruments peers
Updated Oct 27, 2026
Book Value per Share (MRQ)
38.59USDUpdated Oct 27, 2026
Total Assets
11.30BUSD
vs all stocks (USD)
FY2025 · Oct 31, 2025
Total Current Assets
4.35BUSDFY2025 · Oct 31, 2025
Total Liabilities
5.42BUSDFY2025 · Oct 31, 2025
Total Non-current Assets
6.95BUSDFY2025 · Oct 31, 2025
Total Non-current Liabilities
3.57BUSDFY2025 · Oct 31, 2025
Total Current Liabilities
1.85BUSDFY2025 · Oct 31, 2025
Cash & Cash Equivalents
1.87BUSDFY2025 · Oct 31, 2025
Accounts Receivable
939.00MUSDFY2025 · Oct 31, 2025
Inventory
1.05BUSDFY2025 · Oct 31, 2025
Accounts Payable
355.00MUSDFY2025 · Oct 31, 2025
Short-term Debt
51.00MUSDFY2025 · Oct 31, 2025
Deferred Revenue
652.00MUSDFY2025 · Oct 31, 2025
Long-term Debt
2.73BUSDFY2025 · Oct 31, 2025
Other Non-current Liabilities
536.00MUSDFY2025 · Oct 31, 2025
Common Stock (Book)
2.00MUSDFY2025 · Oct 31, 2025
Retained Earnings
7.08BUSDFY2025 · Oct 31, 2025
Total Shareholders' Equity
5.88BUSD
vs all stocks (USD)
FY2025 · Oct 31, 2025
Treasury Stock
3.80BUSDFY2025 · Oct 31, 2025
52-Week Low
165.06USDUpdated Oct 27, 2026
52-Week High
389.93USDUpdated Oct 27, 2026
52-Week Change
97.66%
vs all stocks
Updated Oct 27, 2026
Beta
1.18x
vs all stocks
Updated Oct 27, 2026
50-Day MA
342.05USDUpdated Oct 27, 2026
200-Day MA
313.75USDUpdated Oct 27, 2026
Avg 10-Day Volume
1.31MSharesUpdated Oct 27, 2026
Avg 30-Day Volume
1.23MSharesUpdated Oct 27, 2026
Diluted EPS (TTM)
7.39USDUpdated Oct 27, 2026
Other Income / Expense
200.00MUSDFY2025 · Oct 31, 2025
4 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
More of its sales turn into cash than in its industry, and less of that cash is consumed by reinvestment than at most of its peers.
Reads
FCF Ratios Elevated
Its free cash flow is large next to assets and equity, and more of its operating cash reaches it than in its industry.
Reads
Industry-Benchmarked ROA and Margin Elevated
Returns and margins have sat in the top of its industry across five years.
Reads
How is this stock valued?
Close Below 40W SMA With Profitability
The price sits below its 40-week average, on three profitable years and cash above profit.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
Gross margin is 65.9%, higher than 95% of its Scientific & Technical Instruments peers (median 39.9%)Significant